Authors

• Fitsum Ghebretinsea (ORCID: https://orcid.org/0000-0002-4122-4102)
• Catherine Thomas (ORCID: https://orcid.org/0000-0002-5352-7688)
• Charlotte Gaskell (ORCID: https://orcid.org/0000-0002-6382-2277)
• Aimee Jackson (ORCID: https://orcid.org/0000-0002-9324-9635)
• Adam J. Mead (ORCID: https://orcid.org/0000-0001-8522-1002)
• Graham McIlroy (ORCID: https://orcid.org/0000-0002-4731-1784)
• Claire Harrison
• Robert C. Tasker (ORCID: https://orcid.org/0000-0003-3647-8113)
• Rebecca H. Boucher (ORCID: https://orcid.org/0000-0002-6739-4193)
• Emily Yafai
• M. F. McMullin
• Sonia Fox

Institutions

• National Health Service (GB)
• Queen's University Belfast (GB)
• University of Ulster (GB)
• Belfast City Hospital (GB)
• University of Oxford (GB)
• MRC Weatherall Institute of Molecular Medicine (GB)
• Cancer Research UK Clinical Trials Unit (GB)
• University of Birmingham (GB)
• Medical Research Council (GB)

Publication Details

Journal

BMC Cancer

Published

2025-01-10

DOI

https://doi.org/10.1186/s12885-024-13383-3

Citations

2

Primary Topic

Myeloproliferative Neoplasms: Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

3.25

Funders

• Celgene